Enable Injections LLC

Enable Injections LLC

Enable Injections LLC

Overview
Date Founded

2010

Headquarters

2863 East Sharon Road,Cincinnati, OH 45241

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Medical Products & Equipment
Hospitals & Patient Services
Holding Companies

Company Description

Enable Injections LLC develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH.

Executives & Employees

Chief Commercial Officer & Executive Vice President

Vice President & Chief Financial Officer

Executive Officer

Subscribe now to see full list of current and former executives
Board of Directors

Director, Division of General & Thoracic Surgery at Cincinnati Children's Hospital Medical Center

Venture Partner at Triathlon Medical Venture Partners LLC

Founder at Enable Injections LLC

Principal at Partisan Management Group, Inc.

Managing Director at The Goldman Sachs Group, Inc.

Advisor at Spring Mill Venture Partners

President & Chief Executive Officer at 16 Tech Community Corp.

Subscribe now to see full list of current and former board members
Paths to Enable Injections LLC
Potential Connections via
Relationship Science
You
Enable Injections LLC
Recent Transactions
Details Hidden

Enable Injections LLC raised money in a private placement transaction

Details Hidden

Enable Injections LLC raised money in a private placement transaction

Details Hidden

Enable Injections LLC raised money in a private placement transaction

Subscribe now to see full list of recent transations
Investors
Details Hidden

Cintrifuse Fund Management manages the Cintrifuse Early Stage Capital Fund I, a venture capital fund-of-funds. The fund invests in regional and national early-stage venture capital funds. The fund target venture firms with focus areas that align with its strategic funding partners interests in life sciences, consumer goods and services, technology and energy.

Subscribe now to see full details